Cargando…
Non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: An exception to every rule
Pneumocystis jiroveci associated pneumonia (PCP) is one of the most important opportunistic conditions affecting immunocompromised patients, especially those with rheumatic diseases, often associated with lymphopenia and high serum LDH levels. The risk of PCP correlates with immunomodulators' d...
Autores principales: | Lourenço, Jorge, Carreira, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677122/ https://www.ncbi.nlm.nih.gov/pubmed/33251106 http://dx.doi.org/10.1016/j.rmcr.2020.101289 |
Ejemplares similares
-
To Every Rule There is an Exception: A Rational Extension of Loewenstein's Rule
por: Fant, Magnus, et al.
Publicado: (2021) -
Pneumocystis jirovecii pneumonia induced by low-dose
methotrexate in a patient with chronic urticaria
por: Wang, Sheng-Huei, et al.
Publicado: (2017) -
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection
por: Bermejo-Martin, Jesús F, et al.
Publicado: (2020) -
Methotrexate/steroids: Lymphopenia and Pneumocystis pneumonia: case report
Publicado: (2021) -
Linear low-dose extrapolation for noncancer health effects is the exception, not the rule
por: Rhomberg, Lorenz R, et al.
Publicado: (2011)